News & Insights

CBI Assists Sponsors and Lawyers in Due Diligence for Novosense’s (2676.HK) IPO

CBI Assists Sponsors and Lawyers in Due Diligence for Novosense’s (2676.HK) IPO

08 Dec 2025 Congratulatory Ad

On 8 December 2025, Suzhou Novosense Microelectronics Co., Ltd. (Novosense, 2676.HK) successfully listed on the Main Board of the Hong Kong Stock Exchange (HKEx), raising a total of approximately HKD 2,212 million. CBI is honored to participate in the due diligence work for this IPO Project.

Novosense is a China-based company mainly engaged in the research and development, design and sales of analog chips. The Company's products cover sensors, signal chains and power management, and are used in the automotive, pan-energy and consumer electronics fields.

In this IPO project, CBI primarily assisted the sponsor team in conducting due diligence on the company group, its directors, senior management, shareholders, customers and suppliers. In addition to the basic information such as litigation, bankruptcy, winding-up and media records, CBI also assisted the sponsor team in conducting reputation intelligence and related company searches. The due diligence project globally covered 5 countries and regions, including China, Hong Kong, South Korea, Germany, and Isreal, etc.